Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Prevention efforts reduce hepatitis B virus-associated polyarteritis nodosa cases
November 18th, 2005
Prevention efforts reduce hepatitis B virus (HBV)-associated polyarteritis nodosa (PAN) cases. According to recent research published in the journal Medicine, "HBV-associated HBV-PAN is a typical form of classic PAN whose pathogenesis has been attributed to immune-complex deposition with antigen excess." "We conducted the current study to 1) analyze the frequency of HBV infection in patients with PAN, in light of the classification systems described since 1990; 2) describe the clinical characteristics of HBV-PAN; 3) compare the evolution according to conventional or antiviral treatment; and 4) evaluate long-term outcome," said L. Guillevin and...
Source: Drug Week (2005-11-18)
|
